These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6868491)

  • 21. [Effects of slow nitrate by products in heart patients at rest and during cyclo-ergometric tests (author's transl)].
    Boutefeu JM; Righetti A; Rutishauser W
    Ann Cardiol Angeiol (Paris); 1979; 28(2):129-34. PubMed ID: 378089
    [No Abstract]   [Full Text] [Related]  

  • 22. [Changes in the antioxidant enzyme activity of the blood in patients with ischemic heart disease during treatment with nitrosorbide].
    Lankin VZ; Katsenovich ER; Kostko SZ; Tikhaze AK; Mitina VM
    Kardiologiia; 1987 Oct; 27(10):117-9. PubMed ID: 3695073
    [No Abstract]   [Full Text] [Related]  

  • 23. [Isosorbitol dinitrate in patients with coronary diseases. Study using radioisotope cineventriculography during isotonic exercise in horizontal dorsal position].
    Savioli RM; Federico WA; de Britto FS; Nassif M; Alonso G; Martins LR; Del Nero Júnior E
    Arq Bras Cardiol; 1982 Jun; 38(6):489-94. PubMed ID: 7168679
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of parasympathetic blockade on ischemic threshold in patients with exercise-induced myocardial ischemia.
    Marraccini P; Orsini E; Nassi G; L'Abbate A
    Am J Cardiol; 1991 Aug; 68(5):539-42. PubMed ID: 1872284
    [No Abstract]   [Full Text] [Related]  

  • 25. [Approaches to the personal antianginal therapy. Can we consider nitrosorbide as a drug of choice?].
    Zhiliaev EV; Glazunov AV; Koroba GS
    Klin Med (Mosk); 1994; 72(4):62-4. PubMed ID: 7990387
    [No Abstract]   [Full Text] [Related]  

  • 26. [Drug therapy of coronary heart disease. Comparative effects of nifedipine and isosorbide dinitrate].
    Böhm C; Christl HL; Wald G
    Med Welt; 1982 Sep; 33(36):1242-4. PubMed ID: 7132675
    [No Abstract]   [Full Text] [Related]  

  • 27. [Effect of 50 mg isosorbide-5-nitrate retard on the stress tolerance of patients with coronary heart disease].
    Eggeling T; Jansen W; Osterspey A; Tauchert M; Hilger HH
    Med Klin (Munich); 1986 Apr; 81(8):275-80. PubMed ID: 3785087
    [No Abstract]   [Full Text] [Related]  

  • 28. [Combined therapy with nitrosorbide and preductal in patients with ischemic heart disease].
    Tiurin VP; Chernov SA; Korneev NV; Chernov MIu; Kutepov IuS; Virs EA; Davydova TV; Makarenkova LA; Spicheva IA; Sharonova SP
    Voen Med Zh; 2000 Nov; 321(11):34-7. PubMed ID: 11302103
    [No Abstract]   [Full Text] [Related]  

  • 29. Patient self-reporting of compliance does not correspond with electronic monitoring: an evaluation using isosorbide dinitrate as a model drug.
    Straka RJ; Fish JT; Benson SR; Suh JT
    Pharmacotherapy; 1997; 17(1):126-32. PubMed ID: 9017773
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effectiveness of nitrosorbide, corinfar and obsidan in preventing ischemia caused by the dipyridamole test].
    Furkalo NK; Lutaĭ MI; Simorot VN; Zaĭtseva VI
    Kardiologiia; 1987 Nov; 27(11):68-72. PubMed ID: 3437668
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Nitrosorbide in the complex treatment of chronic cor pulmonale].
    Zamotaev IP; Ibadova GD; Zakharova GIu; Vorob'eva ZV; Lozinskiĭ LG
    Sov Med; 1988; (1):64-7. PubMed ID: 3363420
    [No Abstract]   [Full Text] [Related]  

  • 32. [Treatment of coronary insufficiency. Comparative study on the effect of a nitro compound (isosorbidedinitrate), a beta sympatholytic (bupranolol) and a drug combination (oxycardin)].
    Philipp R; Kutscha W
    Med Welt; 1980 May; 31(21):817-20. PubMed ID: 7392937
    [No Abstract]   [Full Text] [Related]  

  • 33. [Clinical experiences with the Kö 1366 (Bunitrololhydrochloride) beta receptor blockader and the combination Kö 1366/Isosorbitdinitrate in patients with coronary disease].
    Holzhey P
    Wien Med Wochenschr; 1975 Oct; 125(42-44):624-9. PubMed ID: 5819
    [No Abstract]   [Full Text] [Related]  

  • 34. Oxyfedrine and cardiac inotropism in coronary artery disease.
    Krishnaswami S; Sathyamurthy I; Mao R; Padmakumar P
    Indian Heart J; 1984; 36(3):161-5. PubMed ID: 6490047
    [No Abstract]   [Full Text] [Related]  

  • 35. [Comparison of dinitrate isosorbide retard forms in ischemic heart disease patients with stable effort angina].
    Lupanov VP; Alekseeva IA; Vasil'eva NN; Komar OA; Romasiuk SS; Naumov VG
    Ter Arkh; 2000; 72(9):33-6. PubMed ID: 11076413
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical study on "sini" decoction on treating stenocardia for coronary heart disease].
    Liang Y
    Zhong Yao Cai; 2005 Aug; 28(8):737-9. PubMed ID: 16379430
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Value of Iso Mack Retard in the treatment of coronary disease].
    Zminkowska U; Markiewicz M
    Wiad Lek; 1984 Apr; 37(7):496-500. PubMed ID: 6385487
    [No Abstract]   [Full Text] [Related]  

  • 38. [Treatment of ischemic heart disease with verapamil].
    Ostapiuk FE; Dobrotvorskaia TE; Khavazha KhA
    Sov Med; 1985; (11):78-81. PubMed ID: 4089643
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of drugs on myocardial perfusion scanning and wall motion in patients with coronary insufficiency.
    Simon H; Felix R; Hedde J
    Acta Med Scand Suppl; 1978; 615():85-91. PubMed ID: 358767
    [No Abstract]   [Full Text] [Related]  

  • 40. [Ergometric and clinical results of treating coronary disease with isosorbide dinitrate and verapamil].
    Pozenel H
    Med Welt; 1981 Jun; 32(24):988-92. PubMed ID: 7253907
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.